Next Article in Journal
First Case of Whipple’s Disease Successfully Treated With Tigecycline
Previous Article in Journal
Erratum
 
 
GERMS is published by MDPI from Volume 15 Issue 4 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with the former publisher Infection Science Forum.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Effect of Multidimensional Intervention To Reduce Surgical Site Infection Rate After Knee and Hip Arthroplasty

by
Samar Saeed Morsi
1,2,
Abeer Omar
3,
Gautam Hebbar
4,
Mariam Al-Fadhli
4 and
Wafaa S. Hamza
4,5,*
1
Department of Microbiology and Immunology, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt
2
Infection Control, Al-Razi Orthopedic Hospital, Sabah Health Region, Alshamiya P.O. Box 12414, Kuwait
3
Surveillance Department, Infection Control Directorate, Ministry of Health, Sabah Health Region, Alshamiya P.O. Box 12414, Kuwait
4
Infection Control Directorate, Ministry of Health, Sabah Health Region, Alshamiya P.O. Box 12414, Kuwait
5
Department of Public Health and Community Medicine, Faculty of Medicine, Assiut University, Assiut 71526, Egypt
*
Author to whom correspondence should be addressed.
GERMS 2021, 11(1), 10-22; https://doi.org/10.18683/germs.2021.1236
Submission received: 20 July 2020 / Revised: 17 November 2020 / Accepted: 30 December 2020 / Published: 15 March 2021

Abstract

Introduction: Prevention strategies are critical to reduce infection rates in joint arthroplasty. This study aimed to investigate the effectiveness of a set of evidence-based practices to reduce surgical site infection (SSI) rates after knee and hip arthroplasty (HPRO & KPRO). Methods: A quasi-experimental study design (comparing pre- and post-intervention phases) was applied. Interventions were selected, adapted, and implemented in knee and hip arthroplasty procedures as a prospective practice. They consisted of 13 processes throughout the surgical encounter, including preoperative, intraoperative, and postoperative elements. Results: Regarding hip arthroplasty procedures, the overall SSI rate during the pre-intervention period was 11.9%, which was reduced significantly to 5.1% (57% reduction) in the intervention period (p = 0.042). For knee arthroplasty procedures, the overall baseline SSI rate during the pre-intervention period was 2.7%, which was reduced to 2.0% (26% reduction) in the intervention period. However, this reduction was not statistically significant (p = 0.561). Combined methicillin-resistant Staphylococcus aureus (MRSA) screening with appropriate decolonization and targeted prophylaxis were associated with a 50% reduction in SSI caused by MRSA in knee arthroplasty. Conclusions: The implementation of multidimensional evidence-based practices was associated with a reduction in SSI following knee and hip arthroplasties.

Introduction

Joint diseases tend to occur more frequently among the elderly. Pain and restricted movement are both associated with such diseases, and joint injuries noticeably affect the quality of life over time. Therefore, joint replacement procedures to reduce pain and increase movement capability are among the most common surgical procedures currently applied. Although remarkable rehabilitation is typically evident in the lives of patients after joint prosthesis, possible complications have been identified [1].
Infection represents one potential complication that needs to be minimized, and which both challenges the success of the surgical procedure and presents a burden to both the patient and the medical facility. At best, infections following hip and knee arthroplasty lead to additional pain, discomfort, and longer durations of hospitalization and treatment [2]. Furthermore, if the infections worsen, this could result in further revisions with even longer hospitalization, more surgical procedures, and higher costs [3].
The rate of infection in patients undergoing knee and hip replacements shows considerable variation among countries. Nevertheless, the high frequency of these procedures translates these varying rates into a substantial burden of infection [4]. Prevention strategies are critical to reducing infection rates in joint arthroplasty, but evidence-based consensus guidelines on the prevention of surgical site infections (SSI) continue to be heterogeneous [5]. Numerous studies related to infections in arthroplasty have been published over the last decade, which sought to identify patients at risk for the development of SSIs, and determine methods to reduce the incidence of SSIs by altering modifiable risk factors and improving perioperative and postoperative factors [4,5].
To the best of our knowledge, no previous studies on infections associated with hip and knee arthroplasty have been conducted in Kuwait. Hence, this study aimed to investigate the effectiveness of a set of evidence-based practices in reducing the SSI rate after knee and hip arthroplasty.

Methods

Study design

A quasi-experimental study design (comparing pre- and post-intervention phases) throughout a 36-month period was applied; the study was conducted in three stages: pre-intervention (baseline) period for 16 months from January 2014 through April 2015; preparatory period for 4 months from May to August 2015, in order to establish the elements of the intervention; an intervention period for 16 months from September 2015 through December 2016.

Study setting

The study was conducted at Al-Razi Orthopedic tertiary care hospital, which is equipped with 480 beds. It is the only specialized orthopedic hospital performing hip and knee arthroplasty in the state of Kuwait.

Data collection

Data were collected by the infection control team at the hospital through consistent, comprehensive, prospective SSI surveillance of hip and knee arthroplasties. The hospital has one full-time infection control physician and seven infection control nurses, based on its bed capacity. Data on SSIs were collected using the surveillance forms of the Kuwait National Healthcare-associated Infection Surveillance System (KNHSS), adopted from the Centers for Disease Control and Prevention National Healthcare Safety Network (CDC/NHSN) surveillance protocol of surgical site infection 2013 [6,7]. The following denominator, nominator, and post-discharge SSI forms were used for the hip and knee arthroplasty surgical procedures. Patients who underwent the selected surgical procedures were prospectively and dynamically tracked for signs of SSI and followed up to 90 days after the procedure as part of the KNHSS.
Trained infection control nurses completed a surgical denominator form for each procedure performed at the study hospital. The denominator form included personal data, including name, age, sex, nationality, and hospital ID number. Additional surgery-related data included the name of the procedure, code, date and duration, surgical wound class, the American Society for Anesthesiologists (ASA) score, use of scope, emergency or not, and the category of the SSI Risk Index. Infections were identified either during the primary admission for surgery, during outpatient follow-up for the surgical incision site, or on readmission to the hospital. During post-discharge surveillance, the SSIs were detected using the following methods described below.

Diagnosis of SSI during original admission

To diagnose postoperative SSIs, which developed during the original surgical procedure, a nominator form was completed that included personal data, such as name, sex, date of birth, hospital ID number, date of admission, nationality; and procedural data, such as name, code, and date. In addition, the following data were recorded: date of infection, SSI type, signs, symptoms, results of laboratory investigation, physician’s diagnosis, identified microorganism(s) and susceptibility, whether secondary bloodstream infection developed, and patient outcome (deceased or discharge).

Diagnosis of SSI after patient discharge

Post-discharge surveillance was applied to diagnose SSIs either after patient discharge or on readmission. The post-discharge surveillance form was completed for patients who returned with an SSI to the Al-Razi emergency department, outpatient clinics, primary healthcare center, or any general hospital. The post-discharge surveillance form indicated the name of the hospital at which the operation was performed, the name of the reporting hospital/clinic, as well as the patients’ personal data. Sources included registers from surgery, emergency departments, outpatient clinics, and primary healthcare centers. A nominator form was also completed for these patients.
During post-discharge follow-up visits, healthcare workers examined patients for any signs of an SSI, and wound dressings were changed at a primary healthcare center or the study hospital’s emergency department or clinics. In most cases, these visits were based on the previous written follow-up schedule. On a monthly basis, the infection control team actively collected all patient data using standardized post-discharge surveillance methods from the primary healthcare centers and hospitals. During the post-discharge period, all diagnosed cases at any government facility were included, and comprehensive data were gathered (nominator forms were completed). All relevant forms were made available at all government hospitals and primary healthcare centers. The nursing staff at these locations were trained to complete the relevant forms. The team collected all completed forms from all locations on a regular daily basis.

Definitions

The SSI and a patient’s risk index categories definitions were based up on the CDC guideline. SSIs were categorized into three groups: superficial, involving skin and subcutaneous tissue; deep, involving muscle and fascia; and organ space. Wounds were divided into four classes: clean, clean-contaminated, contaminated, or dirty-infected according to the NHSN that was adjusted from the American College of Surgeons classification. The NHSN cutoff point (75th percentile) for the duration of the operative procedures was specified in minutes: 120 for hip arthroplasty (HPRO) & 119 for knee arthroplasty (KPRO) surgeries. The American Society of Anesthesiologists classified the patient’s preoperative physical condition from 1-5 using the ASA classification. The NHSN surgical risk index category was calculated for all operated patients. The NHSN SSI Risk Index varies from 0 (least risk) to 3 (highest risk), and it is the summation of a number of risk factors: 1) an operation time longer than the duration cut-off point. 2) a surgical wound class of contaminated or dirty/infected; and 3) a patient with an ASA score of 3, 4 or 5; 2) Each risk factor listed was considered as one risk according to the NHSN risk index. SSIs were defined for all patients who underwent the selected surgeries during the study period at the study site and acquired an SSI according to the CDC criteria [6].

Ethical considerations

Kuwait ministry of health standing committee for the coordination of health and medical research approved the study protocol and a copy of the research protocol after approval was circulated in the study site.

Inclusion and exclusion criteria

All patients who underwent primary HPRO and KPRO were included, while patients who had revision arthroplasty or did not have primary skin closure were excluded. In the intervention period we recruited only the cases that were fully compliant with the interventions to measure the impact of the different interventions on the rate of SSI.

Intervention characteristics

Elements of the intervention were selected, adapted, and implemented in hip and knee arthroplasty procedures as a prospective practice. The intervention consisted of 13 processes throughout the surgical encounter, including preoperative, intraoperative, and postoperative elements [8,9,10] (Table 1); the details of the interventions are available in supplementary file.
Before applying the intervention, the elements were discussed with the attending surgeons, nurses, and surgical team. The entire team was taught to effectively apply the elements in their routine practice. Monitoring of adherence to the intervention processes was achieved through direct observation of the healthcare workers by the infection control team. Observation days were randomly selected every week throughout the study period and a checklist was used.

Data analyses

Data were coded, entered, and analyzed using the SPSS statistical software package (version 18) for Windows (SPSS Inc, Chicago, IL). For quantitative variables, a simple descriptive measure was reported, as the research data were normally distributed (mean ± standard deviation), and frequency with percentage distribution was reported for qualitative variables. Continuous variables were compared between the pre-intervention and intervention periods using the two-sample t-test, while either the Chi squared or Fisher’s exact test was used to compare categorical variables. The SSI rates per 100 surgical procedures were calculated for the baseline and intervention periods, based on the CDC/NHSN protocol 2013 [6]. All p values <0.05 were considered statistically significant.

Results

Between January 2014 and December 2016, 276 primary HPRO and 697 primary KPRO procedures were studied. Patient demographics were relatively well balanced between the two periods in the two procedures with no difference in age, general anesthesia, emergency cases, ASA score, total/partial hip arthroplasty ratio (p>0.05). However, there was a statistically significant reduction in the median duration of HPRO procedures during the intervention period (120 min) compared to the pre-intervention period (135 min) (p=0.001). Twenty seven percent of HPRO procedures were following trauma in the pre-intervention compared to 47.7% in the intervention period. This difference was statistically significant (p=0.001)—Table 2.
Regarding HPRO procedures the overall SSI rate during the pre-intervention period was 11.9%, which reduced significantly to 5.1% in the intervention period (with 57% reduction) (p=0.042)—Table 3.
There was a reduction in superficial SSI rate from 5.9% in the baseline period to 1.1% in the intervention period and from 5.9% to 4% in deep SSI rate. However, none of these was statistically significant—Table 3, Figure 1A,B. Moreover, there was no statistically significant difference between the two periods in the SSI rates stratified by SSI risk index category or by the time of development of infection (p>0.05)—Table 3.
In the pre-intervention period, 66.7% of all organisms cultured were Gram-negative bacilli while 33.3% were Gram-positive cocci. An opposite distribution was seen in the intervention period with 87.5% of all organisms being Gram-positive cocci and only 12.5% being Gram-negative bacilli. However, coagulase-negative staphylococci were the most commonly cultured organisms in both periods (28.6% and 62.5% respectively)—Table 4.
The only isolated strain of Escherichia coli, 2 of 3 isolates of Klebsiella pneumoniae, and 1 of 2 isolates of Proteus mirabilis were ESBL producers while 1 of 2 isolates of Staphylococcus aureus was MRSA.
Regarding KPRO procedures, the baseline overall SSI rate during the pre-intervention period was 2.7%, which reduced to 2.0% in the intervention period (26% reduction). However, this reduction was not statistically significant (p=0.561)—Table 3.
There was a reduction in each of the superficial and deep SSI rates by 23% from 1.3% in the pre-intervention period to 1.0% in the intervention period. However, these reductions were not statistically significant (p=0.730)—Table 3, Figure 2A,B.
Moreover, there was no statistically significant difference between the two periods in the SSI rates stratified by SSI risk index category or by the time of development of infection (p>0.05)—Table 3. Gram positive cocci were the predominant organisms in both periods. In the pre-intervention period, 71.4% of all organisms cultured were Gram-positive cocci and 28.6% were Gram-negative bacilli. In the intervention period, 60% of were Gram-positive cocci and 40% were Gram-negative bacilli—Table 4. S. aureus was the most commonly cultured organism (57.1%) while the most common causative microorganisms of SSI in the intervention period were S. aureus, coagulase-negative staphylococci, and P. mirabilis (20% each). In the pre-intervention period, 2 of 4 isolates of S. aureus were MRSA while no MRSA was reported in the intervention period (p>0.05).

Discussion

Effective prevention of SSIs requires an understanding of the associated risk factors and application of evidence-based practice interventions to deliver quality healthcare and ensure better patient outcomes. Furthermore, preventive strategies could help to sustain the continual change in healthcare practices [11].
Several measures have been reported to reduce SSIs following knee and/or hip arthroplasty. Various investigators have proposed and implemented different strategies to reduce the number of SSI complications following arthroplasty, with good results. Matt et al. [12]. concluded that active surveillance with feedback to the surgical team, combined with several SSI prevention interventions aimed at training and observation, evidently lower SSI rates by 42% and 16% after hip and knee arthroplasty, respectively.
Matsen et al. [13]. observed that the effectiveness of implementing a multimodal program to reduce the incidence of periprosthetic joint infection (PJI) after total joint arthroplasty resulted in a reduction in the PJI rate from 1% to 0.4%. Hogenmiller and colleagues [14] reported that the number of total hip arthroplasty (THA)/total knee arthroplasty (TKA) SSIs was reduced to zero following implementation of a best-practice strategy that included five key elements: pre-operative bathing with 2% chlorhexidine gluconate, use of skin and nasal antiseptic, patient warming 30 min prior to and during surgery, pre-operative antibiotic infusion and team huddle prior to patient entry into the operating room to review completion of the checklist and to coordinate start time for opening of instruments.
In the present study, we intensively applied 13 evidence-based processes, which were not consistently applied at our hospital before the intervention period. We successfully demonstrated a statistically significant reduction in the overall hip arthroplasty SSI rate. We achieved our goal of reducing the devastating complication and improving patient outcomes. Moreover, we succeeded in establishing better institutional practices, which will be implemented for future surgical procedures. However, reductions were not significant among sub-analyses by infection classification (superficial or deep), and this could be explained by the small sample size.
Prolonged operative duration is a known risk factor for SSIs in hip and knee arthroplasties [15]. Surgeon experience is also a known risk factor for SSIs and may have a direct impact on operative duration [16]. In the present investigation, the duration of hip arthroplasty procedures was found to be significantly shorter during the intervention period, in comparison to the baseline period. This factor could have played a role in the reduction of the SSI rate during the intervention period.
In knee arthroplasty procedures, SSI rates were evidently reduced by 26% after the intervention. Although this reduction was not statistically significant, we still consider it to be of clinical importance to the outcome of individual patients.
We identified Gram-positive cocci from 64.7% of SSIs associated with knee arthroplasty and 48.2% of SSIs associated with hip arthroplasty. Previous studies have reported the major role of Gram-positive cocci in SSIs following knee and hip arthroplasty [2,17]. In the present investigation, S. aureus was the most common isolate from SSIs associated with knee arthroplasty procedures; however, it accounted for only 6.9% of the isolates associated with hip arthroplasty procedures (for both pre-intervention and intervention phases). Earlier studies have also reported S. aureus as the most common causative organism of SSIs following hip and knee arthroplasty procedures [2].
S. aureus is reportedly carried by 20-30% of patients who have undergone TKA or THA [18]. Compared with non-carriers, S. aureus carriers have a seven-fold increased risk of developing an SSI [19]. Therefore, S. aureus presents a real burden to patients undergoing total hip and knee arthroplasty, as they are identified as high-risk patients for SSIs [20]. Perl et al. [21]. reported 84.6% of S. aureus infections were caused by the same identical strains of S. aureus isolated from the patients’ nares.
Infections with MRSA have caused serious problems in healthcare settings, owing to its ability to produce a biofilm on the implant, thereby creating the perfect environment for survival and multiplication of bacteria, as well as antibiotic resistance [7]. Nasal colonization with MRSA, as documented in previous studies, is one of the major risk factors for developing an SSI, with rates reaching as high as 44% in MRSA-colonized patients, compared with only 2% in non-colonized patients [22]. These findings show that nasal MRSA colonization can lead to a higher risk of developing an SSI, especially in orthopedic patients.
In the present study, combined MRSA screening with appropriate decolonization and targeted prophylaxis was associated with a 50% reduction in SSIs caused by MRSA in knee arthroplasty. Similar findings have been reported by Bebko et al. [23]. and Lamagni [2].
Targeted use of vancomycin in patients undergoing revision TKA is effective in reducing the overall rate of PJI, and PJI resulting from methicillin-resistant organisms [24]. Based on our results, we recommend screening for S. aureus and appropriate decolonization of all patients undergoing hip or knee arthroplasty (both methicillin-resistant and methicillin-sensitive).
Surveillance of SSIs with appropriate feedback to surgeons has been shown to be an important element of effective approaches to reduce SSI risk. A successful surveillance program consists of the use of epidemiologically-related infection definitions and active surveillance means, stratification of SSI rates according to risk factors associated with SSI, and data feedback [10]. One of the strengths of our investigation includes the consistent surveillance methods applied to detect SSIs throughout the study period. The infection control team used the same definition and methods to identify and report SSIs during the pre-intervention and intervention periods.
Another strength of the present study is the application of post-discharge surveillance as an element of the intervention. Our aim was to identify all cases to determine the true SSI rate. As previously reported, post-discharge surveillance and extending surveillance both to outpatients and inpatients is crucial [25].

Conclusions

The implementation of multidimensional evidence-based practices was associated with a reduction in SSIs following knee and hip arthroplasty procedures. Achieving a prolonged and continuous implementation of this approach is needed to maintain improved outcomes.

Supplementary

Supplementary Table 1. Interventions to reduce surgical site infection in hip and knee arthroplasty.
Supplementary Table 1. Interventions to reduce surgical site infection in hip and knee arthroplasty.
Germs 11 00010 i005aGerms 11 00010 i005b

Author Contributions

S.S.M. contributed to: conceptualization, project administration, data curation, methodology, writing: original draft preparation, review & editing. A.O. contributed to: writing review & editing, and validation. G.H. contributed to: data curation and formal analysis. M.A.F. contributed to: supervision. W.S.H. contributed to: methodology, formal analysis, writing: original draft preparation, review & editing. All authors read and approval the final version of the manuscript.

Funding

None to declare.

Conflicts of interest

All authors—none to declare.

References

  1. Widmer, A.F. New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis. 2001, 33 (Suppl. S2), 94–106. [Google Scholar] [CrossRef] [PubMed]
  2. Lamagni, T. Epidemiology and burden of prosthetic joint infections. J Antimicrob Chemother. 2014, 69 (Suppl. S1), i5-10. [Google Scholar] [CrossRef] [PubMed]
  3. Mistry, J.B.; Naqvi, A.; Chughtai, M.; et al. Decreasing the incidence of surgical-site infections after total joint arthroplasty. Am J Orthop (Belle Mead NJ). 2017, 46, E374–E387. [Google Scholar] [PubMed]
  4. Springer, B.D.; Cahue, S.; Etkin, C.D.; Lewallen, D.G.; McGrory, B.J. Infection burden in total hip and knee arthroplasties: An international registry-based perspective. Arthroplast Today. 2017, 3, 137–140. [Google Scholar] [CrossRef] [PubMed]
  5. Ricciardi, B.F.; Bostrom, M.P.; Lidgren, L.; Ranstam, J.; Merollini, K.M.; W-Dahl, A. Prevention of surgical site infection in total joint arthroplasty: An international tertiary care center survey. HSS J. 2014, 10, 45–51. [Google Scholar] [CrossRef] [PubMed]
  6. National Healthcare Safety Network. Surgical Site Infection (SSI) Event Centers for Disease Control and Prevention; Atlanta 2013. Available online: http://www.cdc.gov/nhsn/PDFs/pscManual/9pscSSI current.PDF (accessed on 1 May 2013).
  7. Kuwait National Healthcare-associated Infections Surveillance System. Surgical Site Infection (SSI) Event. Available online: www.icdkwt.com/surveillance_out/ssi/KNHSSSSIproto col2013.pdf (accessed on 1 January 2017).
  8. Goyal, N.; Aggarwal, V.; Parvizi, J. Methicillin-resistant Staphylococcus aureus screening in total joint arthroplasty: A worthwhile endeavor. J Knee Surg. 2012, 25, 37–43. [Google Scholar] [CrossRef] [PubMed]
  9. Institute for Healthcare Improvement (IHI). How-to Guide: Prevent Surgical Site Infection for Hip and Knee Arthroplasty; Institute for Healthcare Improvement (IHI): Cambridge, MA, 2012. [Google Scholar]
  10. Mangram, A.J.; Horan, T.C.; Pearson, M.L.; Silver, L.C.; Jarvis, W.R.; Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol. 1999, 20, 250–278; quiz 279-80. [Google Scholar] [CrossRef] [PubMed]
  11. Mori, C. Implementing evidence-based practice to reduce infections following arthroplasty. Orthop Nurs. 2015, 34, 188–194; quiz 195-6. [Google Scholar] [CrossRef] [PubMed]
  12. Matt, M.; Clohisy, J.; Warren, D.; Hopkins-Broyles, D.; McMullen, K. Decreased surgical site infection (SSI) rates for hip and knee arthroplasty following multiple infection control interventions. Am J Infect Control. 2005, 33, 168–169. [Google Scholar] [CrossRef]
  13. Matsen Ko, L.J.; Yoo, J.Y.; Maltenfort, M.; Hughes, A.; Smith, E.B.; Sharkey, P.F. The effect of implementing a multimodal approach on the rates of periprosthetic joint infection after total joint arthroplasty. J Arthroplasty. 2016, 31, 451–455. [Google Scholar] [CrossRef] [PubMed]
  14. Hogenmiller, J.R.; Hamilton, J.; Clayman, T.; et al. Preventing orthopedic total joint replacement SSIs through a comprehensive best practice bundle/checklist. In Proceedings of the APIC National Conference, Baltimore, MD, June 2011. [Google Scholar] [CrossRef]
  15. Namba, R.S.; Inacio, M.C.; Paxton, E.W. Risk factors associated with deep surgical site infections after primary total knee arthroplasty: An analysis of 56,216 knees. J Bone Joint Surg Am. 2013, 95, 775–782. [Google Scholar] [CrossRef] [PubMed]
  16. Lau, R.L.; Perruccio, A.V.; Gandhi, R.; Mahomed, N.N. The role of surgeon volume on patient outcome in total knee arthroplasty: A systematic review of the literature. BMC Musculoskelet Disord. 2012, 13, 250. [Google Scholar] [CrossRef] [PubMed]
  17. European Centre for Disease Prevention and Control. Annual Epidemiological Report 2016—Surgical Site Infections; ECDC: Stockholm, 2016. [Google Scholar]
  18. Courville, X.F.; Tomek, I.M.; Kirkland, K.B.; Birhle, M.; Kantor, S.R.; Finlayson, S.R. Cost-effectiveness of preoperative nasal mupirocin treatment in preventing surgical site infection in patients undergoing total hip and knee arthroplasty: A cost-effectiveness analysis. Infect Control Hosp Epidemiol. 2012, 33, 152–159. [Google Scholar] [CrossRef] [PubMed]
  19. Ramos, N.; Skeete, F.; Haas, J.P.; et al. Surgical site infection prevention initiative—Patient attitude and compliance. Bull NYU Hosp Jt Dis. 2011, 69, 312–315. [Google Scholar] [PubMed]
  20. Mufarrih, S.H.; Qureshi, N.Q.; Sadruddin, A.; Hashmi, P.; Mahmood, S.F.; Zafar, A.; Noordin, S. Relationship between Staphylococcus aureus carriage and surgical site infections following total hip and knee arthroplasty in the South Asian population: Protocol for a prospective cohort study. JMIR Res Protoc. 2018, 7, e10219. [Google Scholar] [CrossRef] [PubMed]
  21. Perl, T.M.; Cullen, J.J.; Wenzel, R.P.; et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med. 2002, 346, 1871–1877. [Google Scholar] [CrossRef] [PubMed]
  22. Pofahl, W.E.; Goettler, C.E.; Ramsey, K.M.; Cochran, M.K.; Nobles, D.L.; Rotondo, M.F. Active surveillance screening of MRSA and eradication of the carrier state decreases surgical-site infections caused by MRSA. J Am Coll Surg. 2009, 208, 981–986; discussion 986-8. [Google Scholar] [CrossRef] [PubMed]
  23. Bebko, S.P.; Green, D.M.; Awad, S.S. Effect of a preoperative decontamination protocol on surgical site infections in patients undergoing elective orthopedic surgery with hardware implantation. JAMA Surg. 2015, 150, 390–395. [Google Scholar] [CrossRef] [PubMed]
  24. Liu, C.; Kakis, A.; Nichols, A.; Ries, M.D.; Vail, T.P.; Bozic, K.J. Targeted use of vancomycin as perioperative prophylaxis reduces periprosthetic joint infection in revision TKA. Clin Orthop Relat Res. 2014, 472, 227–231. [Google Scholar] [CrossRef] [PubMed]
  25. Ashraf, I.; Mohib, Y.; Hasan, O.; Malik, A.; Ahmad, K.; Noordin, S. Surgical site infection surveillance following total knee arthroplasty: Tertiary care hospital experience. Ann Med Surg (Lond). 2018, 31, 14–16. [Google Scholar] [CrossRef] [PubMed]
Figure 1. (A). Overall monthly primary HPRO SSI infection rates over time. (B). Superficial and deep primary HPRO monthly SSI infection rates over time.
Figure 1. (A). Overall monthly primary HPRO SSI infection rates over time. (B). Superficial and deep primary HPRO monthly SSI infection rates over time.
Germs 11 00010 g001
Figure 2. (A). Overall monthly primary KPRO SSI infection rates over time. (B). Superficial and deep primary KPRO monthly SSI infection rates over time.
Figure 2. (A). Overall monthly primary KPRO SSI infection rates over time. (B). Superficial and deep primary KPRO monthly SSI infection rates over time.
Germs 11 00010 g002
Table 1. Interventions to reduce surgical site infection in hip and knee arthroplasty.
Table 1. Interventions to reduce surgical site infection in hip and knee arthroplasty.
Germs 11 00010 i001
Table 2. Characteristics of patients who underwent primary HPRO and KPRO procedures in the pre-intervention and intervention periods.
Table 2. Characteristics of patients who underwent primary HPRO and KPRO procedures in the pre-intervention and intervention periods.
Germs 11 00010 i002
Chi square or fisher exact p value presented for categorical variables and two sample t test p value presented for continuous variables. *Missing; ASA—American Society for Anesthesiologists; GA—general anesthesia; HPRO—hip arthroplasty; KPRO—knee arthroplasty; SD—standard deviation.
Table 3. Comparison of primary HPRO and KPRO surgical site infection (SSI) rates in the pre-intervention and intervention periods.
Table 3. Comparison of primary HPRO and KPRO surgical site infection (SSI) rates in the pre-intervention and intervention periods.
Germs 11 00010 i003
Chi square or fisher exact p value presented for categorical variables. CI—confidence interval; HPRO—hip arthroplasty; KPRO—knee arthroplasty.
Table 4. Microorganisms isolated from primary HPRO and KPRO surgical site infections, pre- intervention vs. intervention.
Table 4. Microorganisms isolated from primary HPRO and KPRO surgical site infections, pre- intervention vs. intervention.
Germs 11 00010 i004
HPRO—hip arthroplasty; KPRO—knee arthroplasty.

Share and Cite

MDPI and ACS Style

Morsi, S.S.; Omar, A.; Hebbar, G.; Al-Fadhli, M.; Hamza, W.S. Effect of Multidimensional Intervention To Reduce Surgical Site Infection Rate After Knee and Hip Arthroplasty. GERMS 2021, 11, 10-22. https://doi.org/10.18683/germs.2021.1236

AMA Style

Morsi SS, Omar A, Hebbar G, Al-Fadhli M, Hamza WS. Effect of Multidimensional Intervention To Reduce Surgical Site Infection Rate After Knee and Hip Arthroplasty. GERMS. 2021; 11(1):10-22. https://doi.org/10.18683/germs.2021.1236

Chicago/Turabian Style

Morsi, Samar Saeed, Abeer Omar, Gautam Hebbar, Mariam Al-Fadhli, and Wafaa S. Hamza. 2021. "Effect of Multidimensional Intervention To Reduce Surgical Site Infection Rate After Knee and Hip Arthroplasty" GERMS 11, no. 1: 10-22. https://doi.org/10.18683/germs.2021.1236

APA Style

Morsi, S. S., Omar, A., Hebbar, G., Al-Fadhli, M., & Hamza, W. S. (2021). Effect of Multidimensional Intervention To Reduce Surgical Site Infection Rate After Knee and Hip Arthroplasty. GERMS, 11(1), 10-22. https://doi.org/10.18683/germs.2021.1236

Article Metrics

Back to TopTop